Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Scripps

- PMLiVE

J&J wins FDA panel backing for hepatitis C drug

Simeprevir would challenge Victrelis and Incivek if approved

- PMLiVE

J&J files HIV combination in Europe

Seeks approval for fixed-dose tablet containing Prezista and Gilead’s cobicistat

- PMLiVE

Former FDA head to join J&J

Mark McClellan elected to pharma company’s board

- PMLiVE

Buoyant pharma sales drive J&J’s Q3 results

Defies downturn with European growth of 12 per cent

- PMLiVE

US obesity campaign launches

The OAC’s ‘Your Weight Matters’ campaign aims to encourage Americans to discuss weight issues with their healthcare providers

- PMLiVE

How Russian lifestyles are affecting the nation’s healthcare

Russian lifestyles present a significant challenge to the country’s health services

- PMLiVE

GSK gets OK for second quadrivalent flu vaccine in US

FDA approves Flulaval Quadrivalent

- PMLiVE

Malaria vaccine gives “unprecedented” results

Able to protect 12 out of 15 people in phase I trial

- PMLiVE

FDA approves intravenous Simponi for arthritis treatment

J&J says Simponi Aria will offer less frequent dosing schedule than subcutaneous version

- PMLiVE

Pfizer wins new European approval for Prevenar 13

Expands use of pneumococcal disease vaccine to cover people aged 18 to 49

- PMLiVE

Novartis enters developing nations vaccines partnership

Will work with Biological E to deliver vaccines for typhoid and paratyphoid A fevers

- PMLiVE

J&J extends open innovation with Stevenage office

Site at Stevenage Bioscience Catalyst expands London Innovation Centre operations

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links